Page last updated: 2024-11-02

pentobarbital and Sarcoma

pentobarbital has been researched along with Sarcoma in 1 studies

Pentobarbital: A short-acting barbiturate that is effective as a sedative and hypnotic (but not as an anti-anxiety) agent and is usually given orally. It is prescribed more frequently for sleep induction than for sedation but, like similar agents, may lose its effectiveness by the second week of continued administration. (From AMA Drug Evaluations Annual, 1994, p236)
pentobarbital : A member of the class of barbiturates, the structure of which is that of barbituric acid substituted at C-5 by ethyl and sec-pentyl groups.

Sarcoma: A connective tissue neoplasm formed by proliferation of mesodermal cells; it is usually highly malignant.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Denekamp, J1
Terry, NH1
Sheldon, PW1
Chu, AM1

Other Studies

1 other study available for pentobarbital and Sarcoma

ArticleYear
The effect of pentobarbital anaesthesia on the radiosensitivity of four mouse tumours.
    International journal of radiation biology and related studies in physics, chemistry, and medicine, 1979, Volume: 35, Issue:3

    Topics: Animals; Carcinoma, Squamous Cell; Dose-Response Relationship, Radiation; Male; Methods; Mice; Neopl

1979